We are live on ! Find out more
KIM

Kestra Investment Management Portfolio holdings

AUM $5.16B
1-Year Est. Return 18.64%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
+18.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.19B
AUM Growth
+$647M
Cap. Flow
+$689M
Cap. Flow %
21.58%
Top 10 Hldgs %
44.97%
Holding
1,451
New
297
Increased
336
Reduced
262
Closed
554
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
226
Caterpillar
CAT
$393B
$679K 0.02%
2,060
+737
+56% +$263K
JNPR
227
DELISTED
Juniper Networks
JNPR
$679K 0.02%
18,757
+13,319
+245% +$487K
PM icon
228
Philip Morris
PM
$294B
$675K 0.02%
4,215
-7,529
-64% -$1.07M
HEFA icon
229
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.81B
$668K 0.02%
18,410
+6,056
+49% +$221K
ADP icon
230
Automatic Data Processing
ADP
$110B
$667K 0.02%
2,184
+1,043
+91% +$315K
ROKU icon
231
Roku
ROKU
$22.9B
$656K 0.02%
9,311
+2,383
+34% +$191K
ADBE icon
232
Adobe
ADBE
$108B
$656K 0.02%
1,710
+354
+26% +$152K
SAM icon
233
Boston Beer
SAM
$1.9B
$653K 0.02%
+2,732
New +$666K
HIW icon
234
Highwoods Properties
HIW
$3.51B
$644K 0.02%
21,714
-7,885
-27% -$230K
MSCI icon
235
MSCI
MSCI
$41.8B
$644K 0.02%
1,138
+270
+31% +$157K
FCPT icon
236
Four Corners Property Trust
FCPT
$2.76B
$643K 0.02%
22,418
+1,618
+8% +$45.2K
VLY icon
237
Valley National Bancorp
VLY
$8.3B
$642K 0.02%
72,253
-7,199
-9% -$68.1K
BMY icon
238
Bristol-Myers Squibb
BMY
$132B
$642K 0.02%
10,520
+2,691
+34% +$157K
TGT icon
239
Target
TGT
$70.6B
$625K 0.02%
5,992
-2,769
-32% -$346K
DINO icon
240
HF Sinclair
DINO
$16.3B
$624K 0.02%
18,992
+7,245
+62% +$254K
CAH icon
241
Cardinal Health
CAH
$53.8B
$617K 0.02%
4,482
+1,218
+37% +$155K
IPG
242
DELISTED
Interpublic Group of Companies
IPG
$615K 0.02%
22,644
+4,082
+22% +$112K
DUHP icon
243
Dimensional US High Profitability ETF
DUHP
$12.8B
$614K 0.02%
18,528
+12,953
+232% +$445K
FR icon
244
First Industrial Realty Trust
FR
$8.4B
$612K 0.02%
11,341
+7,654
+208% +$414K
ATO icon
245
Atmos Energy
ATO
$28.7B
$599K 0.02%
3,875
+1,277
+49% +$186K
ISRG icon
246
Intuitive Surgical
ISRG
$142B
$598K 0.02%
1,207
+751
+165% +$415K
IVW icon
247
iShares S&P 500 Growth ETF
IVW
$77.9B
$593K 0.02%
6,392
+2,560
+67% +$258K
WFC icon
248
Wells Fargo
WFC
$266B
$587K 0.02%
8,180
-93
-1% -$6.98K
BAC icon
249
Bank of America
BAC
$448B
$585K 0.02%
14,030
-2,086
-13% -$93K
MANH icon
250
Manhattan Associates
MANH
$11.7B
$578K 0.02%
3,341
+1,286
+63% +$268K

Similar funds

Kestra Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, Kestra Investment Management held 1,451 positions worth $3.19B, up 25% from $2.54B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Kestra Investment Management deployed $689M of net new capital in Q1 2025, opening 297 new positions and adding to 336 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 1,034,846 shares worth $54.2M.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.7% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Morningstar Small-Cap Value ETF, an estimated $22.5M trimmed.

  • Kestra Investment Management's largest Q1 2025 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 1,034,846 shares worth $54.2M.
  • Kestra Investment Management added most to Vanguard Morningstar Mid-Cap ETF in Q1 2025, an estimated $77.1M increase.
  • Kestra Investment Management's biggest Q1 2025 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $22.5M.
  • Kestra Investment Management fully exited iShares Russell 2500 ETF in Q1 2025, selling an estimated $37.4M.
  • Kestra Investment Management's ten largest holdings make up 45% of its $3.19B portfolio in Q1 2025.
  • Kestra Investment Management opened 297 new positions and closed 554 in Q1 2025.
  • Kestra Investment Management's portfolio value rose 25% quarter-over-quarter to $3.19B.

Based on Kestra Investment Management's 13F filing for Q1 2025, filed 16 May 2025.